摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(S)-4-aminohexanoic acid | 1334472-86-4

中文名称
——
中文别名
——
英文名称
(S)-4-aminohexanoic acid
英文别名
(4S)-4-Aminohexanoic acid
(S)-4-aminohexanoic acid化学式
CAS
1334472-86-4
化学式
C6H13NO2
mdl
MFCD20441443
分子量
131.175
InChiKey
ROFNJLCLYMMXCT-YFKPBYRVSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -2.2
  • 重原子数:
    9
  • 可旋转键数:
    4
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.83
  • 拓扑面积:
    63.3
  • 氢给体数:
    2
  • 氢受体数:
    3

反应信息

  • 作为反应物:
    描述:
    (S)-4-aminohexanoic acid盐酸-N-乙基-Nˊ-(3-二甲氨基丙基)碳二亚胺 作用下, 生成 (S)-5-ethylpyrrolidin-2-one
    参考文献:
    名称:
    通过工程胺脱氢酶立体选择性合成结构多样 (S)-内酰胺
    摘要:
    光学纯内酰胺具有广泛的应用,其中之一是作为合成农业生物活性化合物或药物的重要中间体。制造这些重要化学品需要在温和条件下用低成本胺供体高效立体选择性合成手性内酰胺。在此,设计了一种两步化学酶促策略,通过改造来自Thermoanaerobacter thermohydrosulfuricus ( Tther AmDH)的天然胺脱氢酶来生产 ( S )-内酰胺。其他AmDH 经过八个定向进化循环,以增强其对酮酸底物的还原胺化活性。这些变体对 6 种测试底物显示出更高的比活性,并在 γ- 和 δ- 内酰胺的不对称合成中提供高达 99% 的高立体选择性。特别是,Tther AmDH V8对模型底物乙酰丙酸表现出高 237 倍的比活性,并产生 99% ee的 ( S )-5-甲基-2-吡咯烷酮,时空产率为 75.3 g L -1  d -1。这些结果表明,工程化的胺脱氢酶Tther AmDH 可以作为
    DOI:
    10.1002/adsc.202200891
  • 作为产物:
    描述:
    (4S)-4-hydrazinylhexanoic acid 在 氢气 作用下, 以 乙醇乙酸乙酯 为溶剂, 20.0 ℃ 、1.01 MPa 条件下, 反应 12.0h, 以21.7 mg的产率得到(S)-4-aminohexanoic acid
    参考文献:
    名称:
    Highly Enantioselective γ-Amination of α,β-Unsaturated Acyl Chlorides with Azodicarboxylates: Efficient Synthesis of Chiral γ-Amino Acid Derivatives
    摘要:
    The cinchona alkaloid-catalyzed gamma-amination of alpha,beta-unsaturated acyl chlorides with azodicarboxylates to give the corresponding dihydropyridazinones in good yields with high enantioselectivities has been developed. Reductive ring opening of the dihydropyridazinones afforded series of cyclic and acyclic gamma-amino acid derivatives in good yields with high enantiopurity.
    DOI:
    10.1021/ja206819y
点击查看最新优质反应信息

文献信息

  • Design, synthesis and application of a new type of bifunctional Le-Phos in highly enantioselective γ-addition reactions of N-centered nucleophiles to allenoates
    作者:Haile Qiu、Xiaofeng Chen、Junliang Zhang
    DOI:10.1039/c9sc04073k
    日期:——

    A novel class of bifunctional cyclic phosphine catalysts (Le-Phos) is reported, which showed good performances in enantioselective γ-addition reactions of N-centered nucleophiles and allenoates under mild conditions.

    一种新型的双功能环磷催化剂(Le-Phos)被报道,它在温和条件下对N-中心亲核试剂和烯酸酯的对映选择性γ-加成反应中表现出良好的性能。
  • CONFORMATIONALLY CONSTRAINED, FULLY SYNTHETIC MACROCYCLIC COMPOUNDS
    申请人:POLYPHOR AG
    公开号:US20150051183A1
    公开(公告)日:2015-02-19
    The conformationally restricted, spatially defined macrocyclic ring system of formula (I) is constituted by three distinct molecular parts: Template A, conformation Modulator B and Bridge C. Macrocycles described by this ring system I are readily manufactured by parallel synthesis or combinatorial chemistry in solution or on solid phase. They are designed to interact with a variety of specific biological target classes, examples being agonistic or antagonistic activity on G-protein coupled receptors (GPCRs), inhibitory activity on enzymes or antimicrobial activity. In particular, these macrocycles show inhibitory activity on endothelin converting enzyme of subtype 1 (ECE-1) and/or the cysteine protease cathepsin S (CatS), and/or act as antagonists of the oxytocin (OT) receptor, thyrotropin-releasing hormone (TRH) receptor and/or leukotriene B4 (LTB4) receptor, and/or as agonists of the bombesin 3 (BB3) receptor, and/or show antimicrobial activity against at least one bacterial strain. Thus they are showing great potential as medicaments for a variety of diseases.
    公式(I)的构象受限、空间定义的大环环系统由三个不同的分子部分组成:模板A、构象调节剂B和桥C。由这种环系统I描述的大环可通过并行合成或溶液中或固相上的组合化学轻松制造。它们被设计用于与各种特定生物靶标类相互作用,例如在G蛋白偶联受体(GPCR)上的激动或拮抗活性,酶的抑制活性或抗菌活性。特别是,这些大环显示对亚型1的内皮素转化酶(ECE-1)和/或半胱氨酸蛋白酶卡特普辛S(CatS)的抑制活性,和/或作为催产素(OT)受体、促甲状腺释放激素(TRH)受体和/或白三烯B4(LTB4)受体的拮抗剂,和/或作为瘤胃素3(BB3)受体的激动剂,和/或对至少一种细菌菌株显示抗菌活性。因此,它们显示出作为各种疾病药物的巨大潜力。
  • [EN] CONFORMATIONALLY CONSTRAINED, FULLY SYNTHETIC MACROCYCLIC COMPOUNDS<br/>[FR] COMPOSÉS MACROCYCLIQUES ENTIÈREMENT SYNTHÉTIQUES ET À CONFORMATION CONTRAINTE
    申请人:POLYPHOR AG
    公开号:WO2013139697A1
    公开(公告)日:2013-09-26
    The conformationally restricted, spatially defined macrocyclic ring system of formula (I) is constituted by three distinct molecular parts: Template A, conformation Modulator B and Bridge C. Macrocycles described by this ring system I are readily manufactured by parallel synthesis or combinatorial chemistry in solution or on solid phase. They are designed to interact with a variety of specific biological target classes, examples being agonistic or antagonistic activity on G-protein coupled receptors (GPCRs), inhibitory activity on enzymes or antimicrobial activity. In particular, these macrocycles show inhibitory activity on endothelin converting enzyme of subtype 1 (ECE-1 ) and/or the cysteine protease cathepsin S (CatS), and/or act as antagonists of the oxytocin (OT) receptor, thyrotropin-releasing hormone (TRH) receptor and/or leukotriene B4 (LTB4) receptor, and/or as agonists of the bombesin 3 (BB3) receptor, and/or show antimicrobial activity against at least one bacterial strain. Thus they are showing great potential as medicaments for a variety of diseases.
    公式(I)的构象受限、空间定义明确的大环环形系统由三个不同的分子部分构成:模板A、构象调制剂B和桥梁C。由该环系统I描述的大环可通过溶液中的并行合成或组合化学,或者在固相上制造。它们被设计用来与各种特定生物靶标类相互作用,例如在G蛋白偶联受体(GPCR)上的激动或拮抗活性,对酶的抑制活性或抗菌活性。特别是,这些大环显示对第1亚型内皮素转化酶(ECE-1)和/或半胱氨酸蛋白酶S(CatS)的抑制活性,和/或作为催产素(OT)受体、促甲状腺释放激素(TRH)受体和/或白三烯B4(LTB4)受体的拮抗剂,和/或作为瘤胃肽3(BB3)受体的激动剂,和/或对至少一种细菌菌株显示抗菌活性。因此,它们显示出作为各种疾病药物的巨大潜力。
  • Advanced drug development and manufacturing
    申请人:Los Alamos National Security, LLC
    公开号:EP2511844A2
    公开(公告)日:2012-10-17
    There is described an apparatus for measuring protein characteristics comprising an X-ray fluorescence (XRF) spectrometer comprising a source of polychromatic X-rays, an X-ray detector, a protein, a molecule that has been exposed to and at least weakly binds to the protein, a plurality of X-ray fluorescence signal data obtained by irradiating chemical elements in the protein and molecule with the polychromatic X-rays and a security system for maintaining records for the data from the plurality of X-ray fluorescence signal measurements. There is also described an x-ray microscope for measuring a sample.
    描述了一种测量蛋白质特性的仪器,该仪器包括一个 X 射线荧光 (XRF) 光谱仪,其中包括一个多色 X 射线源、一个 X 射线探测器、一个蛋白质、一个已暴露于该蛋白质并至少与该蛋白质弱结合的分子、通过用多色 X 射线照射蛋白质和分子中的化学元素而获得的多个 X 射线荧光信号数据,以及一个用于维护多个 X 射线荧光信号测量数据记录的安全系统。此外,还介绍了一种用于测量样品的 X 射线显微镜。
  • Conformationally constrained, fully synthetic macrocyclic compounds
    申请人:POLYPHOR AG
    公开号:US10017481B2
    公开(公告)日:2018-07-10
    The conformationally restricted, spatially defined macrocyclic ring system of formula (I) is constituted by three distinct molecular parts: Template A, conformation Modulator B and Bridge C. Macrocycles described by this ring system I are readily manufactured by parallel synthesis or combinatorial chemistry in solution or on solid phase. They are designed to interact with a variety of specific biological target classes, examples being agonistic or antagonistic activity on G-protein coupled receptors (GPCRs), inhibitory activity on enzymes or antimicrobial activity. In particular, these macrocycles show inhibitory activity on endothelin converting enzyme of subtype 1 (ECE-1) and/or the cysteine protease cathepsin S (CatS), and/or act as antagonists of the oxytocin (OT) receptor, thyrotropin-releasing hormone (TRH) receptor and/or leukotriene B4 (LTB4) receptor, and/or as agonists of the bombesin 3 (BB3) receptor, and/or show antimicrobial activity against at least one bacterial strain. Thus they are showing great potential as medicaments for a variety of diseases.
    式(I)的构象受限、空间限定的大环环系统由三个不同的分子部分构成,分别是模板 A、构象调节剂 B 和桥 C:这种环系统 I 所描述的大环很容易通过平行合成或组合化学在溶液或固相中制造出来。它们可与各种特定的生物靶标相互作用,例如对 G 蛋白偶联受体(GPCR)的激动或拮抗活性、对酶的抑制活性或抗菌活性。特别是,这些大环化合物对亚型 1 内皮素转换酶(ECE-1)和/或半胱氨酸蛋白酶 cathepsin S(CatS)具有抑制活性,和/或可作为催产素(OT)受体的拮抗剂、或白三烯 B4(LTB4)受体的拮抗剂,和/或作为弹力素 3(BB3)受体的激动剂,和/或对至少一种细菌菌株具有抗菌活性。因此,它们作为治疗各种疾病的药物显示出巨大的潜力。
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物